Modern-day inhaled and nasal drug product development is a balancing act, made even more complicated by a changing regulatory landscape. Helping to navigate this evolving industry, CDMOs are an indispensable source of support and have a crucial role to play in helping pharma companies chart the best route forward.
In the latest issue of PMPS, our experts share what best practices look like in drug device development and how to find a CDMO that will maximise the chances of achieving commercial success.
